Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

346 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Usability and acceptability of home-based self-testing for SARS-CoV-2 antibodies for population surveillance.
Atchison C, Pristerà P, Cooper E, Papageorgiou V, Redd R, Piggin M, Flower B, Fontana G, Satkunarajah S, Ashrafian H, Lawrence-Jones A, Naar L, Chigwende J, Gibbard S, Riley S, Darzi A, Elliott P, Ashby D, Barclay W, Cooke GS, Ward H. Atchison C, et al. Among authors: barclay w. Clin Infect Dis. 2020 Aug 12:ciaa1178. doi: 10.1093/cid/ciaa1178. Online ahead of print. Clin Infect Dis. 2020. PMID: 32785665 Free PMC article.
ACE2: The Only Thing That Matters?
Sanchez-David RY, Swann OC, Peacock TP, Barclay WS. Sanchez-David RY, et al. Am J Respir Crit Care Med. 2020 Jul 15;202(2):161-163. doi: 10.1164/rccm.202006-2151ED. Am J Respir Crit Care Med. 2020. PMID: 32520592 Free PMC article. No abstract available.
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia.
Braga L, Ali H, Secco I, Chiavacci E, Neves G, Goldhill D, Penn R, Jimenez-Guardeño JM, Ortega-Prieto AM, Bussani R, Cannatà A, Rizzari G, Collesi C, Schneider E, Arosio D, Shah AM, Barclay WS, Malim MH, Burrone J, Giacca M. Braga L, et al. Among authors: barclay ws. Nature. 2021 Apr 7. doi: 10.1038/s41586-021-03491-6. Online ahead of print. Nature. 2021. PMID: 33827113
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.
Thwaites RS, Sanchez Sevilla Uruchurtu A, Siggins MK, Liew F, Russell CD, Moore SC, Fairfield C, Carter E, Abrams S, Short CE, Thaventhiran T, Bergstrom E, Gardener Z, Ascough S, Chiu C, Docherty AB, Hunt D, Crow YJ, Solomon T, Taylor GP, Turtle L, Harrison EM, Dunning J, Semple MG, Baillie JK, Openshaw PJ; ISARIC4C investigators. Thwaites RS, et al. Sci Immunol. 2021 Mar 10;6(57):eabg9873. doi: 10.1126/sciimmunol.abg9873. Sci Immunol. 2021. PMID: 33692097
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, Carson G, Dunning J, Harrison EM, Baillie JK, Semple MG, Cullinan P, Openshaw PJM; ISARIC investigators. Bloom CI, et al. Lancet Respir Med. 2021 Mar 4:S2213-2600(21)00013-8. doi: 10.1016/S2213-2600(21)00013-8. Online ahead of print. Lancet Respir Med. 2021. PMID: 33676593
346 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page